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Abstract
The clinical application of novel in-vitro fertilisation techniques
involving mitochondrial donation was legalised in the UK in 2015. Mitochondria
contain genetic material and it is possibly not surprising that headlines have described
the resulting baby as having ‘three parents’ – the intending mother and father, and
the egg donor. The techniques raise important questions, including how do we interpret
transfer of biological material from one body to another? What are the implications
for identity? And how, whether or when should the use of these techniques be revealed
to the child? This article has two aims. First, it sets out the key ethical issues raised
by the clinical introduction of mitochondrial donation. Secondly, it presents empirical
data to highlight how patients themselves respond to these ethical questions. It con-
cludes by highlighting how the introduction of medical technologies and the relation-
ships between donors and recipients are dependent on the cultural, historical and social
contexts.
Introduction
In March 2015, UK Parliament voted to change the law to
support the clinical application of novel in-vitro fertilisation (IVF) procedures
which involve the transfer of nuclear material into an enucleated donated egg.
These techniques are widely known as mitochondrial donation. The result is
that the UK is at the cutting edge of mitochondrial science and the only country
in the world to legalise germ-line technologies. Scientific, medical and patient
communities across the world have closely followed the developments with
interest. In September 2015, theHuman Fertilisation and Embryology Authority
(HFEA) announced their plans for how centres will be licensed andwhat expec-
tations will be placed on those centres to engage in monitoring babies born
using the technique. It is expected that the first cohort of ‘three parent’ babies
will be born in the UK in 2016, and as was the case following the birth of the
first IVF baby, Louise Brown, in 1978 and again when she gave birth to her first
child at the age of 28, it might be expected that the health and development of
these children, and potentially their future childrenwill be watchedwith interest.
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The techniques have attracted intense scientific, media and public interest,
with spectres of 'three parent babies’, ‘slippery slopes’ and Frankenstein science
competing for headline space alongside stories of womenwho have experienced
the pain of losing a child to mitochondrial disease. Behind the alarming head-
lines, techniques ofmitochondrial donation raise important questions for society.
These include how we should understand the transfer of genetic material from
one body to another, how this might impact on the child’s identity and how,
whether or when children should be told about this intervention. This article
aims to do two things. First, it aims to set out the key ethical issues raised by
the development and clinical introduction ofmitochondrial donation. Secondly,
based on research exploring the patient experience of mitochondrial disease, it
presents empirical data to highlight how patients themselves respond to these
ethical questions. Although much has been speculated about the widespread
support of these techniques by patients and patient groups, and the importance
of listening to those views, this is the first article to present the views of patients
in the context of recent legislation. The techniques and the political process
have raised many complex issues. This article focuses on three issues: ‘three
parent babies’, anonymity and disclosure. These topics not only illuminate some
of the key aspects of the mitochondria debate but also have resonance for ex-
ploring the social and ethical aspects of many other techniques involving
donation.
Research Methods
This article draws on the analysis of 21 semi-structured inter-
views conducted with patients diagnosed with maternally inherited mitochon-
drial disease. The aim of this project was twofold: to explore the patient experi-
ence of mitochondrial disease and to understand patients’ perspectives on mi-
tochondrial donation. Ethical approval was gained through theNorth ScotlandRe-
search Ethics Committee and participants were contacted through a national
mitochondria research clinic. All names have been changed to ensure anonymity.
The interviews lasted between one and two hours, and a loosely structured in-
terview schedule was followed. The topics discussed included the experience
of diagnosis, health management, communication strategies within the family
and the role of reproductive technologies. Based on the author’s previous expe-
rience of interviewing patients with mitochondrial disease and the difficulties
of talking about controversial technologies, small cards were produced with
statements printed on them, which were then used to prompt discussion. These
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cards were initially prepared as part of Q methodology,1 an established method
within psychology which has now been developed to explore public understand-
ing of science, health behaviours and technologies.2 This article also draws on
publicly accessible reports prepared by the Department of Health, HFEA and
Nuffield Council on Bioethics.
What is mitochondria and mitochondrial disease?
Mitochondria are small structures in the cytoplasm of a cell.
The 37 genes contained in mitochondrial DNA are primarily responsible for
producing the cell’s energy, and make up less than 0.1% of our body’s total
DNA. Mitochondrial disease is caused when the mitochondria fail to function,
the results of which can be extremely variable in terms of symptoms and severity.
Symptoms can include diabetes, deafness, epilepsy, digestive disorders and
extreme fatigue, and for many patients, the disease is progressive. The term
‘mitochondrial disease’ encompasses a range of disorders, includingmitochon-
drial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)
Leber’s hereditary optic neuropathy (LHON) and Leigh syndrome.
Asmitochondria are derived through the oocyte, disease caused bymutations
of mitochondrial DNA are only inherited through the female line. This means
that while both sexes can inherit the disease it is only women who are at risk
of transmitting the disease to their children. There is no cure for mitochondrial
disease and the treatment options, which formost people will be strong vitamins,
has limited results. In this context, the development of techniques which can
prevent a child from inheriting the disease have been widely welcomed. Scien-
tists at the Wellcome Trust Centre for Mitochondrial Research in Newcastle
have developed two related techniques which involve the ‘donation’ of healthy
mitochondria within an IVF cycle. Maternal spindle transfer involves removing
the nucleus of the egg and placing it into a donated, enucleated egg. Pro-nuclear
transfer involves a similar process but occurs after fertilisation. Both techniques
are reported to offer women with mitochondrial disease the only opportunity
for having healthy, genetically related children.
As the donor’s mitochondria could be inherited by future generations, the
techniques are germ-line, and a change in UK law was required for them to be
offered to patients. The transition from laboratory to clinic has involved intense
S. Watts & P. Stenner,Doing QMethodological Research: Theory, Method and Interpretation (Lon-
don: Sage 2012).
1
H. Farrimond & S.E. Kelly, ‘Public viewpoints on novel non-invasive technologies for prenatal
genetic diagnosis’, Public Understanding of Science, 22:6 (2013), 736-750.
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and extensive enquiry and debate, reflecting its controversial nature, and national
and international significance. The process involved three scientific reviews by
an expert panel,3 a dialogue exercise to assess public attitudes4, a call for evidence
on the ethical issues organised by the Nuffield Council on Bioethics5, a public
consultation6 and government guidance on draft regulations led by the UK
Department of Health,7 and several debates at the House of Commons8 and
House of Lords.9
‘Three parent babies’
Asmitochondria contain genetic material, it is not surprising
that ideas about what this might mean for genetic identity and parentage have
captured the imagination, been used in alarmist headlines, and come under
scrutiny. ‘Three parent babies’ headlines have primarily dominated the debate,10
alongside more subtle ideas of ‘three person IVF’, ‘three person babies’ and
‘three person DNA’.11 Based on the extent of the genetic contribution and the
function of the genes involved, the Department of Health does not accept that
a child born through mitochondrial donation would have three parents:
HFEA, Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease
through assisted conception: update 2014, www.hfea.gov.uk/8807.html (last accessed 22/9/2015).
3
HFEA,Mitochondria replacement consultation: Advice to Government. March 2013, www.hfea.gov.4
uk/docs/HFEA_Authority_meeting_March_2013_-_Mitchondria_report.pdf (last accessed
22/9/2015).
Nuffield Council on Bioethics,Novel techniques for the prevention of mitochondrial DNA disorders:
an ethical Review (London: Nuffield Council on Bioethics, 2012), www.nuffieldbioethics.org/
5
mitochondrial-dna-disorders (last accessed 22/9/2015).
Department of Health,Mitochondrial Donation: A consultation on draft regulations to permit the
use of new treatment techniques to prevent the transmission of a serious mitochondrial disease from
mother to child (2014), https://www.gov.uk/government/uploads/system/uploads/attachment_
6
data/file/285251/mitochondrial_donation_consultation_document_24_02_14_Access-
ible_V0.4.pdf (last accessed 22/9/2015).
Department of Health,Mitochondrial Donation: Government response to the consultation on draft
regulations to permit the use of new treatment techniques to prevent the transmission of a serious
mitochondrial disease from mother to child (2014), https://www.gov.uk/government/uploads/
7
system/uploads/attachment_data/file/332881/Consultation_response.pdf (last accessed 22/9/
2015).
Houses of Commons debate 3 February 2015, www.publications.parliament.uk/pa/cm201415/8
cmhansrd/cm150203/debtext/150203-0002.htm (last accessed 22/9/2015).
House of Lords debate 24 February 2015, www.publications.parliament.uk/pa/ld201415/9
ldhansrd/text/150224-0002.htm (last accessed 22/9/2015).
‘Britain is first to legalise three-parent IVF’, The Times (25 February 2015), www.thetimes.10
co.uk/tto/science/article4364732.ece (last accessed 22/9/2015).
Sulston et al., ‘Three-person IVF’, The Times (letter, 28 January 2015), www.thetimes.co.11
uk/tto/opinion/letters/article4337474.ece (last accessed 22/9/2015).
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‘Genetically, the child will, indeed, have DNA from three individuals but all
available scientific evidence indicates that the genes contributing to personal
characteristics and traits come solely from the nuclear DNA, which will only
come from the proposed child’s mother and father. The donatedmitochondrial
DNA will not affect those characteristics.’12
Many of the participants interviewed for this project were aware of the
complexity of the debate and its competing ideas, including the biological sig-
nificance of genetic material and the role of genetics in influencing our identity.
Many highlighted the small contribution of mitochondrial genes that might
render it insignificant in transfer, and that overall, themetaphor of ‘three parent
babies’ was not useful:
‘[People oppose the techniques] thought there’d be three parents involved
and it would pose problems with visiting rights and things, which it wouldn’t
be anything like that. And I did get annoyed and, and like some of the govern-
ment parliament people were standing up and arguing their point against it. I
thought, well if they had a daughter that was suffering and having problems
you wouldn’t be so [opposed] […] they’re taking a gene from another lady but
as regards to her being a parent, no. It’s just like, giving your heart or your lung
to somebody isn’t it? You don’t own them.’ [Participant 19]
‘The dodgy gene is extracted from the mother who wants a child, isn’t it,
her egg? And the healthy gene is put into her egg. So the gene is a just a tiny,
tiny part of it. An egg is part of you, part of your – Well, it’s you. Your hair col-
ouring, your personality, everything. [The donor] has contributed and they’ve
supported and helped somebody, but no, I don't think it’s a three-parent [...]
But just to take a gene, a healthy gene and take away the bad gene, you're doing
it for health reasons. You’re not creating somebody else’s child. Do you know
what I mean? I don’t think they can put a claim to it.’ [Participant 24]
In some cases, the words of the participants concur with the Department
of Health’s advice as described previously. Following this advice, the UK gov-
ernment has set an important precedent: the relationship between child and
donor has been characterised as one where there is no parental obligation on
behalf of the donor.13 This means that while donors will be able to find out
Department of Health,Mitochondrial Donation: Government response to the consultation on draft
regulations to permit the use of new treatment techniques to prevent the transmission of a serious
mitochondrial disease from mother to child (2014) 15, https://www.gov.uk/government/uploads/
12
system/uploads/attachment_data/file/332881/Consultation_response.pdf (last accessed 22/9/
2015).
The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 201513
(SI 2015/572), www.legislation.gov.uk/uksi/2015/572/contents/made?page=5 (last accessed
22/9/2015).
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whether a child has been born using their donation, children will only be able
to access non-identifying information about the donor.
Donor Anonymity
The system of anonymity that will be introduced alongside
mitochondrial donation techniques will have important implications for the
child and their family. Many of the participants held the view that the donor
should remain anonymous:
‘They [the mitochondria donors] have decided that they will donate to help
you have a healthy child, so therefore to me, that’s where the ethics stop. They
don’t have any rights to sort of have contact with the child. They’ve decided they
want to be a donor, hopefully for the right reasons, not that they then want to
have claims on the child that you’re having.’ [Participant 3]
‘It’s like when you give blood; you don’t know where it’s going, but it’s
probably saving somebody’s life. But you don't get to know those people. So,
at the end of the day, if you give genes or cells or whatever it is, bone marrow,
anything, you know somewhere along the line you’ve done somebody some
good, but you don’t know who you’ve done it for. But it’s just something that
you feel is right.’ [Participant 25]
Once again, the words of the participants echo the views of the Department
of Health andUK government. However, included in the legislation is provision
that might open up the opportunity for children and their unknown donors to
make contact. Along with their health records, the donor can provide non-
identifying information about themselves for the child if they wish, and the
clinic can support a voluntary system of contact between the donor and child.
Disclosure
One key recommendation from the Department of Health,
and one that relates to the uncertainty about the safety of the techniques, was
that the health of any child born through mitochondrial donation should be
monitored. Engaging children in follow up naturally raises ethical concerns
about the genetic testing of children,14 and their potential to be medicalised
A.L. Bredenoord & P. Braude, ‘Ethics of mitochondrial gene replacement: from bench to bed-
side’, British Medical Journal (2010) 341.
14
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from a very early age. It is also possible, provided that there is funding in place
and the participants are willing, that this follow up will extend to future gener-
ations. However, one of the key assumptions on which ‘follow up’ is based is
that families will agree to sustained contact with the clinic. However, another
fundamental issue, whichmight be influential in whether or not families engage
in medical services, hinges on disclosure. The participants in this study had
differing views about whether the child should be told:
‘But I think in a way it would be cruel for the children to be told. Because
it confuses things when there’s no need for confusion. Because I think the
mitochondrial donation should be regarded like any other sort of medical pro-
cedure. Because it’s not the same as sperm donation where clearly half of the
genetic material comes from a parent. I think the percentage is so small that
you shouldn’t – I think things should be anonymised.’ [Participant 8]
‘I think they should have a right to know, but I think that it should be ex-
plained first, exactly what has been used and the mind and everything else
hasn’t changed. The only thing that’s changed is they’ve got a healthier life,
and that is thanks to the person that donated. But apart from thanking them
for giving them a better life, they’re not related, it’s just like having a heart by-
pass. Someone’s put something into you that makes you function okay.’ [Par-
ticipant 5]
‘I think the child and the parent might want to have contact later on. Again,
something you might do if you have an adopted child, the child’s choice but
not until a lot later until they’re able tomake that choice. I don’t think you could
say no to them, they’re going to have ways of researching and looking.’ [Partic-
ipant 17]
One of the enduring factors about family life is that many children born
through assisted reproduction and those who are adopted might not be told of
the origins of their birth.15 Thus even after changes to the anonymity laws in
the case of adoption or sperm donation, accessing information about genetic
inheritance relies very much on open disclosure practices of families. With the
only recent legalisation of the techniques, combined with very little published
evidence exploring the patient experience of mitochondrial disease,16 whether
families disclose this information to their child following use of mitochondrial
M. Richards, ‘A British history of collaborative reproduction and the rise of the genetic connec-
tion’, in: T. Freeman, S. Graham, F. Ebtehaj & M. Richards (eds.), Relatedness in Assisted Repro-
duction (Cambridge University Press 2014).
15
R. Dimond, ‘Patient and family trajectories ofmitochondrial disease: diversity, uncertainty and
genetic risk’, Life Sciences, Society and Policy 9 (2013) 1-11.
16
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donation is currently an unknown. This study goes some way to contribute to
knowledge about how families might manage these processes following use of
themitochondrial techniques, and why some families, despite appearing enthu-
siastic at first, might in fact lose contact with the ‘follow up’ clinic.
Discussion
One of the defining characteristics of technologies involving
donation is that they have the potential to produce new social relationships.
Whereas blood donation might be described as an altruistic and anonymous
‘gift’,17 the relationship between a recipient and an organ or tissue donor will
depend on many factors including whether or not the donation is from a living
donor and whether the donor and recipient are already known to each other.
Reproductive technologies are different again, where the relationship between
a sperm or egg donor and resultant child is often more clearly defined within
a legal framework. Mitochondrial donation, which involves the transfer of ge-
netic but not nuclear material transgresses these boundaries and has led to
uncertainty about how the technologies themselves, and the potential relation-
ship between donor and child, should be regulated. The possibility of forging
a relationship between donor and recipient, and the meanings that we give to
these relationships are of course highly dependent on the kinds of technologies
involved and the legal, social and cultural context. The recent legislation, con-
cluding that the mitochondrial donation should not have an obligation towards
the child, is important for how families themselves might make sense of these
technologies.
The accounts of the participants provide further evidence of the complexity
of these decisions. In deciding the role of the mitochondria donor, or whether
the child should know about the techniques, participantsmoved easily between
recognising the importance of genetic knowledge and perceivingmitochondrial
DNA to have a relatively insignificant role. Importantly, participants made a
distinction between donation for reproductive purposes and donation for health
or avoiding illness. This distinction also became important when assessing the
potential role of the mitochondria donor. Being a donor ‘for the right reasons’,
that is, to improve health, led to the conclusion that the person should not then
be allowed to claim a relationship with the child as theymight in cases of sperm
donation or adoption.
Participant accounts highlight how the meanings we attribute to the tech-
niques of mitochondrial donation, mitochondrial DNA and the mitochondria
R. Titmuss, The gift relationship: From human blood to social policy (A. Oakley & J. Ashton eds.,
London: LSE 1997 [1971]).
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donor are developed within a particular context. By frequently comparingmito-
chondrial donation with other kinds of donation, including heart donation,
kidney donation, blood donation and sperm donation, participants revealed the
cultural, historical and social backdrop in which relations between donors and
recipients are played out. Mitochondrial donation is made sense of because it
is categorised as similar, or different, to other kinds of techniques. Mitochon-
drial donation will allow women with mitochondrial disease the opportunity to
have healthy, genetically related children. It is part of a rapidly developing field
of mitochondrial medicine, involving the development of diagnostic technolo-
gies, risk assessment tools and IVF technologies. However, the techniques have
challenged legal and ethical frameworks, and the translation from laboratory
to clinical practice has involved a long period of scrutiny. The techniques have
attracted intense media interest, and strong views have been expressed by na-
tional and international patient and scientific groups. This article has highlighted
the views of patients with mitochondrial disease, and this is an important con-
tribution. Although attitudes often differ about the central importance of mito-
chondrial DNA, this article has shown that patient perspectives, and the debate
itself, cannot be reduced to genetic essentialist reasoning. One aspect that ap-
peared prominent in discussions with patients was the perceived motivations
of donors and parents. The focus on health rather than reproduction is possibly
one of the reasons why the techniques have attracted widespread support. In-
deed, although the techniques might have wider benefit than those with mito-
chondrial disease, other potential uses have been ruled out, including for fertility
purposes18 and for lesbian couples who wish to use the techniques so that both
parties can provide a genetic contribution. Of course questions remain about
what will happen in practice, and many countries across the world will be
watching and waiting with interest as to how children, parents, families, donors
and UK institutions negotiate these contentious issues.
C. Smyth, ‘Allow three-parent IVF to help older women too, says pioneer’, The Times (9 February
2015), www.thetimes.co.uk/tto/health/news/article4348194.ece (last accessed 22/9/2015).
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